<DOC>
	<DOCNO>NCT02181972</DOCNO>
	<brief_summary>The primary objective study assess efficacy safety Gingko biloba film-coated tablet improve cognitive function neuropsychological function middle-aged cognitively intact adult .</brief_summary>
	<brief_title>Efficacy Safety Ginkgo Biloba Middle-aged Cognitively Intact Adults</brief_title>
	<detailed_description />
	<criteria>Male female healthy subject know clinically significant pathology assess investigator MiniMental State Examination ( MMSE ) score â‰¥ 28 Age range : 40 60 , inclusive Females must test negative pregnancy Clinical laboratory test must within normal limit , normal range , clinically acceptable Investigator Urine drug screen illicit drug must negative screening Subjects must give write informed consent accordance ICHGCP ( International Conference Harmonization Good Clinical Practice ) local law regulation Any serious disorder may interfere his/her participation trial evaluation safety test drug Pretreatment and/or concomitant treatment drug may influence trial symptomatology may interfere evaluation cognitive function Alcohol drug abuse accord DSMIV ( Diagnostic Statistics Manual , Version IV ) Individuals drink 6 cup coffee tea/day Individuals smoke 10 cigarettes/day Subjects opinion investigator heavy user tobacco nicotine product Subjects currently take cognition enhance substance , include Ginkgo ginseng product Any subject regularly take medication might stop time active dosing phase , medication deem investigator influence outcome trial Female subject childbearing age use adequate mean birth control Pregnancy and/or lactation Any subject , accord Investigator , unable perform CDR cognitive test neuropsychological test satisfactory consistent manner Relevant allergy know hypersensitivity investigational product excipients Individuals anticoagulant treatment Individuals current disorder likely modify computerise cognitive testing Individuals history cancer ( type , exclude surgically remove treat basal cell carcinoma ) Clinically significant treat thyroid disease Participation another clinical trial within last 3 month prior start study concurrent participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>